09
Jul

Sanofi has filed another lawsuit against Eli Lilly in hopes of beating back a biosimilar challenge for its top-selling insulin product, claiming its rival’s in-development knockoff infringes its intellectual property.

…read more

Source: Sanofi ups the legal ante to block Lilly’s Lantus biosimilar

    

0 No comments